Previous Article | Next Article 
Applied and Environmental Microbiology, May 2000, p. 1917-1922, Vol. 66, No. 5
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Products from the Incomplete Metabolism of Pyrene by Polycyclic
Aromatic Hydrocarbon-Degrading Bacteria
Chikoma
Kazunga and
Michael D.
Aitken*
Department of Environmental Sciences and
Engineering, School of Public Health, University of North Carolina
at Chapel Hill, Chapel Hill, North Carolina 27599-7400
Received 9 December 1999/Accepted 6 March 2000
 |
ABSTRACT |
Pyrene is a regulated pollutant at sites contaminated with
polycyclic aromatic hydrocarbons (PAH). It is mineralized by some bacteria but is also transformed to nonmineral products by a variety of
other PAH-degrading bacteria. We examined the formation of such
products by four bacterial strains and identified and further characterized the most apparently significant of these metabolites. Pseudomonas stutzeri strain P16 and Bacillus
cereus strain P21 transformed pyrene primarily to
cis-4,5-dihydro-4,5-dihydroxypyrene (PYRdHD), the first
intermediate in the known pathway for aerobic bacterial mineralization
of pyrene. Sphingomonas yanoikuyae strain R1
transformed pyrene to PYRdHD and pyrene-4,5-dione (PYRQ). Both strain
R1 and Pseudomonas saccharophila strain P15 transform
PYRdHD to PYRQ nearly stoichiometrically, suggesting that PYRQ is
formed by oxidation of PYRdHD to 4,5-dihydroxypyrene and subsequent
autoxidation of this metabolite. A pyrene-mineralizing organism,
Mycobacterium strain PYR-1, also transforms PYRdHD to PYRQ
at high initial concentrations of PYRdHD. However, strain PYR-1 is able
to use both PYRdHD and PYRQ as growth substrates. PYRdHD strongly
inhibited phenanthrene degradation by strains P15 and R1 but had only a
minor effect on strains P16 and P21. At their aqueous saturation
concentrations, both PYRdHD and PYRQ severely inhibited
benzo[a]pyrene mineralization by strains P15 and R1.
Collectively, these findings suggest that products derived from
pyrene transformation have the potential to accumulate in
PAH-contaminated systems and that such products can significantly
influence the removal of other PAH. However, these products may
be susceptible to subsequent degradation by organisms able to
metabolize pyrene more extensively if such organisms are present in the system.
 |
INTRODUCTION |
Polycyclic aromatic hydrocarbons
(PAH) are known to be degradable by a variety of soil bacteria
(40). Consequently, the bioremediation of PAH contamination
with naturally occurring microorganisms has been attempted at a number
of sites (43, 45). Most of the interest in the
biodegradation of PAH in the field has been in the removal of the
parent compounds, while most research on pure cultures of PAH-degrading
bacteria has focused on their ability to grow on or mineralize specific
PAH substrates. Relatively little attention has been paid to the
potential formation of products from the partial transformation of PAH.
Most of the information that does exist on PAH metabolites has been
obtained in the context of identifying transient metabolites formed by
isolates during growth on the parent compound (13, 33, 35,
40) or metabolites formed by mutants of wild-type degraders
(4, 40). Some bacteria, however, are capable of transforming
one or more PAH despite an inability to grow on or mineralize the PAH
in question (1, 20, 31, 47). It is important to evaluate the
products of such incomplete PAH metabolism because of their potential
effects on PAH-degrading microorganisms or on potentially exposed human
populations (44). Identification of common products of
incomplete metabolism can also be important in assessing the extent to
which natural attenuation may be occurring at contaminated sites
(44).
In a recent study (1), we described the broad PAH substrate
ranges of 11 bacteria isolated from PAH-contaminated soils by
enrichment on phenanthrene as a sole carbon source. None of these
organisms is capable of mineralizing pyrene, yet all could remove
pyrene from solution, and all that were examined further transformed
pyrene to unidentified metabolites (1). The objectives of
this study were to isolate and identify the major products from the
incomplete metabolism of pyrene by four of these organisms, evaluate
the potential degradability of these metabolites by an organism known
to grow on pyrene as a sole carbon source, and determine the effects of
these metabolites on the degradation of phenanthrene, a representative
growth substrate for many PAH degraders, and
benzo[a]pyrene, a representative carcinogenic PAH that is not known to serve as a growth substrate for any organism.
 |
MATERIALS AND METHODS |
Chemicals and media.
Pyrene (99%), osmium tetroxide
(>98%), ruthenium dioxide (99.9%), sodium periodate (99.8%), and
acetone-d6 (99.9%) were obtained from Aldrich
(Milwaukee, Wis.). Phenanthrene (>96%),
[7-14C]benzo[a]pyrene
(7-14C-labeled BaP) (>98%; specific activity, 26.6 mCi
mmol
1), and [4,5,9,10-14C]pyrene (>98%;
specific activity, 61 mCi mmol
1) were obtained from Sigma
(St. Louis, Mo.). All solvents used were high-pressure liquid
chromatography (HPLC) grade or the equivalent. Mineral salts buffer
(MSB) was as described in Stucki et al. (39).
cis-4,5-Dihydro-4,5-dihydroxypyrene (PYRdHD) was synthesized
by oxidation of pyrene with osmium tetroxide (10, 23). The crude product was extracted with 200 ml of hexane to remove unreacted pyrene, recrystallized from acetone, and dried at 50°C for 24 h.
The purity of the synthesized compound was established by the presence
of a single peak in chromatograms from HPLC, and the authenticity was
established by 1H nuclear magnetic resonance (NMR)
spectroscopy. PYRdHD exhibits UV absorbance maxima at 219 and 261 nm.
The 1H NMR shifts recorded for PYRdHD were (in parts per
million) 7.90 (d, 2), 7.84 (s, 2), 7.82 (d, 2), 7.64 (tr, 2), and 5.15 (s, 2).
Pyrene-4,5-dione (PYRQ) was synthesized by the oxidation of pyrene with
ruthenium dioxide and sodium periodate (
17). The
crude
product was dissolved in 50 ml of methylene chloride and
passed through
a column of silica gel, which was eluted successively
with hexane (to
remove unreacted pyrene) and methylene chloride.
Methylene chloride
eluted PYRQ first and then eluted pyrene-1,6-dione
and
pyrene-1,8-dione. The purity and authenticity of synthesized
PYRQ were
established by HPLC and
1H NMR spectroscopy, respectively.
PYRQ exhibits UV-visible light
absorbance maxima at 238, 295, and 432 nm. The
1H NMR shifts for PYRQ were (in parts per million)
8.43 (d, 2),
8.38 (d, 2), 8.05 (s, 2), and 7.88 (tr,
2).
Aqueous solubilities of PYRdHD and PYRQ at room temperature were
determined by adding an excess of either compound to 10 ml
of MSB in
triplicate vials. After 24 h, the samples were filtered
through a
0.02-µm-pore-size alumina filter (Whatman, Maidstone,
England) and
analyzed by HPLC. Concentrations in the filtrate
were quantified
against external standards of the synthesized
compounds.
Organisms.
Pseudomonas saccharophila P15,
Pseudomonas stutzeri P16, Bacillus cereus P21,
and strain R1 were isolated as described elsewhere (1, 38).
Isolate R1 was identified as a strain of Sphingomonas yanoikuyae by MIDI, Inc. (Newark, Del.) on the basis of 16S rRNA gene sequence similarity (500-bp analysis; 1.49% difference from type
strain). Mycobacterium PYR-1 was obtained from C. Cerniglia (National Center for Toxicological Research, Jefferson, Ark.).
Strains P15, P16, P21, and R1 cannot mineralize pyrene but they can all
transform it to non-mineral products (
1). They
were selected
for this study based on differences in PAH metabolism,
as manifested in
part by a limited (P16 and P21) or pronounced
(P15 and R1) ability to
mineralize benz[
a]anthracene, BaP, and
chrysene
(
1). Strain PYR-1 was selected for its ability to
grow on
pyrene as a sole carbon source (
26).
Isolation of metabolites.
Bacteria were grown in 500 ml of
MSB containing 50 mg of phenanthrene, 5 mg of pyrene, and 20 mg (each)
of succinate, peptone, and yeast extract. The cultures were stirred
rapidly with a Teflon stir bar for 2 weeks, after which no phenanthrene
crystals were visible. The samples were centrifuged, filtered through a
1.0-µm-pore-size filter, acidified to pH 2.5 with 20%
H3PO4, and vacuum extracted through 1 g of
octadecyl silica (Supelco, Bellefonte, Pa.). Retained products were
eluted with 20 ml of methanol, which was evaporated under a gentle
stream of N2. The residue was dissolved in 1 ml of acetone
and separated by thin-layer chromatography (TLC) (1000-µm-diameter silica gel, 20 by 20 cm; F254; Whatman) with a 50/50
mixture of hexane and benzene, followed by a 90/10 mixture of benzene
and acetone and finally a 85/10/5 mixture of benzene, acetone, and acetic acid. Bands that fluoresced strongly under UV light (254 nm)
were scraped off the plates, redissolved in acetone, and filtered through a 0.02-µm-pore-size alumina filter (Whatman). The filtrates were evaporated under N2, and then the residue was
dissolved in 300 µl of acetonitrile and analyzed by HPLC. Injections
(150 µl each) were made on a Supelcosil C18 semipreparative column
(25 cm by 10 mm; particle size, 5 µm; Supelco). Fractions were
collected manually, and those from each injection were combined. Then,
each fraction was evaporated under N2 and dissolved in 0.5 ml of acetone-d6 for NMR analysis.
Experiments with metabolites.
Each organism was grown in 500 ml of MSB containing 50 mg of phenanthrene (for strains P15, P16, P21,
and R1) or 50 mg of pyrene (for strain PYR-1) for approximately 1 week,
centrifuged, and resuspended in MSB at an optical density at 420 nm
(OD420) of 0.1 unless stated otherwise. The PAH-degrading
activity of washed-cell suspensions of strains P15, P16, P21, and R1
was verified by measuring the initial rate of phenanthrene degradation
(38) prior to each experiment. Subsequent incubations were
conducted in the dark or in amber vessels on a rotary shaker at
approximately 150 rpm. When added in a particular assay, synthesized
PYRdHD or PYRQ was provided in a solution of acetone or acetonitrile, which was evaporated prior to inoculation with cell suspensions.
Metabolite formation from resting cells pregrown on phenanthrene was
evaluated by incubating a washed-cell suspension (100
µl) in an HPLC
vial insert with approximately 15,000 dpm of [
14C]pyrene
(1.1 µM) dissolved in 5 µl of dimethyl sulfoxide (DMSO).
Reactions
were terminated after 24 h by adding 100 µl of acetonitrile.
Samples were analyzed by HPLC, and fractions were collected every
minute with a Waters (Milford, Mass.) fraction collector. Each
fraction
was supplemented with 3 ml of scintillation cocktail
(ScintiSafe;
Fisher Scientific, Pittsburgh, Pa.) and analyzed
with a Tri-Carb 1900TR
liquid scintillation analyzer (Packard,
Meriden, Conn.).
An isotope-trapping experiment was conducted with strain P15, in which
washed cells pregrown on phenanthrene were incubated
with 50 µM
PYRdHD and [
14C]pyrene. A similar experiment was
conducted with strains P15
and R1, in which each strain was incubated
with 1.6 µM PYRQ and
20,000 dpm of
14C-labeled BaP.
Samples from these experiments were analyzed by
radiochromatography as
described
above.
The transformation of PYRdHD to PYRQ was evaluated for each strain by
incubating triplicate washed-cell suspensions (1 ml
each) in MSB
containing PYRdHD at concentrations identified below.
Reactions were
terminated after 3 days by adding 1 ml of acetonitrile,
and the
supernatants were analyzed by
HPLC.
Effects of pyrene metabolites on the growth of strains P15, P16, P21,
and R1 were determined by incubating washed-cell suspensions
pregrown
on phenanthrene (OD
420 = 0.01) in vials containing 560
µM phenanthrene (added as a concentrated DMSO solution) alone
or with
PYRdHD (155 µM) or PYRQ (16 µM). After 3 days, Pierce
(Rockford,
Ill.) bicinchoninic acid protein assay reagent was
added to each vial,
and the samples were shaken for another 24
h. The absorbance of
the samples at 562 nm was then determined
on a Hitachi (Danbury, Conn.)
U-3300 spectrophotometer. Protein
concentrations were quantified by
comparison to bovine serum albumin
standards dissolved in MSB and
incubated with the samples for
24 h. No growth occurred in
controls containing DMSO
alone.
Growth of strain PYR-1 on PYRdHD or PYRQ as a sole carbon source was
determined with cultures pregrown on pyrene (OD
420 =
0.01). PYRdHD or PYRQ was added to vials at concentrations equivalent
to 500 µM, and cultures were incubated for 4 weeks. Protein
concentrations
were determined as described
above.
The effects of pyrene metabolites on phenanthrene degradation rates
were determined with washed cells pregrown on phenanthrene
and
incubated in MSB for 24 h to remove any residual phenanthrene.
Replicate aliquots (1 ml each) were then added to empty vials
or vials
containing PYRdHD or PYRQ at concentrations equivalent
to 155 or 1.6 µM, respectively. Vials were incubated for 30 min
and then
supplemented with phenanthrene to a concentration of
5.6 µM.
Reactions were terminated by adding 1 ml of acetonitrile
at selected
intervals up to 20 min, and the remaining concentration
of phenanthrene
was determined by HPLC. A first-order (in phenanthrene
concentration)
degradation rate equation was fit to the concentration
versus time data
with Pro-Stat software (Poly Software International,
Sandy,
Utah).
The potential reactivity of PYRQ with biomass or buffer constituents
was determined with triplicate washed-cell suspensions
(5 ml each) of
strain R1 or P15 in vials containing 10 µM PYRQ.
Reactions were
terminated after 3 days by adding 1 ml of acetonitrile,
and the
supernatants were analyzed for residual PYRQ by
HPLC.
The effects of PYRdHD and PYRQ on BaP mineralization by strains P15 and
R1 were determined with triplicate washed-cell suspensions
(5 ml) in
20-ml scintillation vials containing PYRdHD or PYRQ
at concentrations
identified below. Each vial contained a test
tube in which a fluted
strip of filter paper soaked with 150 µl
of 2 N KOH served as a
CO
2 trap (
1). Approximately 20,000 dpm
of
14C-labeled BaP (equivalent to 0.064 µM) was added to
each vial,
which was then capped with a Teflon-lined septum. Positive
controls
did not contain pyrene metabolites, and uninoculated controls
contained 5 ml of MSB supplemented with
14C-labeled BaP.
Incubations were terminated by injecting 0.5 ml
of 20%
H
3PO
4 through the septum. The vials were shaken
for an
additional 24 h, and then the filter paper strips were
placed
in 5 ml of scintillation cocktail and another 5 ml of
scintillation
cocktail was added directly to the sample vials. Samples
were
analyzed by scintillation
counting.
Analyses.
HPLC analyses were conducted on a Waters 600E
system with a Supelcosil C18 column (25 cm by 4.6 mm; particle size, 5 µm; Supelco). Pyrene, PYRdHD, and PYRQ were analyzed with a
photodiode array detector and quantified at 254 nm, and other putative
metabolites were analyzed with fluorescence detection (excitation at
259 nm and emission at 370 nm) or photodiode array detection. The
mobile phase for these analyses was initially a 50/50 ratio of
acetonitrile to water containing 0.01% trifluoroacetic acid, which was
increased to 100% acetonitrile over 20 min; these conditions improved
the separation of metabolites compared to analyses performed in earlier work (1). Phenanthrene was analyzed by detection at 254 nm, with a mobile phase of a 70/30 ratio of acetonitrile to water containing 0.01% trifluoroacetic acid that was increased linearly to
100% acetonitrile over 5 min. The 1H NMR spectra were
recorded on a Varian Inova 500 spectrometer at 500 MHz, with shifts
reported in parts per million relative to the proton resonance of tetramethylsilane.
 |
RESULTS |
Isolation of pyrene metabolites.
Growth of strains P15, P16,
P21, and R1 in a medium containing phenanthrene as a major carbon
source and in the presence of pyrene in excess of its aqueous
solubility resulted in the extracellular accumulation of a number of
pyrene metabolites. The relative quantities of these metabolites were
assessed by the size and strength of the fluorescent bands on TLC
plates. The most significant bands that were isolated by TLC were
purified further by semipreparative HPLC, and the purified compounds
were analyzed by 1H NMR spectroscopy.
The most significant metabolite from isolates P16 and P21 was
identified as PYRdHD (Fig.
1a), which is
the first intermediate
in the aerobic bacterial pathway for metabolism
of pyrene (
13,
24,
33,
35,
49). PYRdHD was one of two
significant products
from strain R1, which also transformed pyrene to
PYRQ (Fig.
1b).
No other isolated TLC bands were identified, including
all those
from strain P15, either because there were insufficient
amounts
for NMR analysis or the NMR spectra could not be characterized.
Optical spectra obtained for the unidentified bands did not match
published spectra of known intermediates in the bacterial degradation
of pyrene (
33).
Identification of PYRdHD and PYRQ was confirmed by comparing the NMR
spectra of the bacterial metabolites to those of the
synthesized
compounds as well as published spectra (
9,
24,
48). The
cis configuration of PYRdHD was established by comparison
to
published
1H NMR spectra of
cis and
trans PYRdHD (
24). The solubility of
PYRdHD in
MSB at room temperature is 155 ± 13 µM (36.7 ± 3.1 mg/l)
and that of PYRQ is 1.6 ± 0.1 µM (0.38 ± 0.01 mg/l).
Transformation of [14C]pyrene by resting cells.
The radiochromatograms of culture fluids from resting cells (Fig.
2) largely confirmed the results obtained
from the transformation of pyrene during active growth of the organisms
on phenanthrene. On the basis of retention time, resting cells of
strains P16 and P21 transformed pyrene primarily to PYRdHD, and strain
R1 transformed pyrene to PYRQ and a number of other minor products.
Strain P15 removed almost the entire amount of
[14C]pyrene in the 24-h incubation period but did not
appear to form significant amounts of PYRdHD or PYRQ. The elevated
baselines in the radiochromatogram for strain P15 after approximately 8 min (Fig. 2a) indicate the formation of numerous other products, which
continued to elute even after the elution of pyrene. Significant amounts of radiolabel also remained in the empty reaction vials for
both strain P15 (approximately 15%) and strain R1 (approximately 30%); in contrast, the recovery of radiolabel in MSB amended with acetonitrile in uninoculated controls was approximately 95%. When incubated with [14C]pyrene in the presence of 50 µM
PYRdHD, strain P15 accumulated small amounts of a single product that
eluted at the same retention time as PYRQ (Fig. 2a). Pyrene removal was
considerably slower in the presence of 50 µM PYRdHD.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Radiochromatograms of culture fluids from 24-hr
incubations of [14C]pyrene with P. saccharophila P15 (a), P. stutzeri P16 (b), B. cereus P21 (c), and S. yanoikuyae R1 (d). The inset to
panel a is the chromatogram from incubation of strain P15 with
[14C]pyrene in the presence of 50 µM PYRdHD for 24 h, at which time most of the PYRdHD was depleted; the chromatogram is
truncated before the much larger peak for unreacted pyrene. Solid lines
are sample chromatograms, and dashed lines are chromatograms from
uninoculated controls. PYRdHD, PYRQ, and pyrene eluted at 14, 19, and
29 min, respectively, under the HPLC conditions used to generate these
chromatograms.
|
|
Metabolism of PYRdHD and PYRQ.
Resting cells of strains R1 and
P15 both converted PYRdHD nearly stoichiometrically to PYRQ,
whereas neither strain P16 nor P21 was able to transform PYRdHD (Table
1). Mycobacterium PYR-1, an organism known to mineralize pyrene, also transformed
PYRdHD to PYRQ to various extents depending on the initial
concentration of PYRdHD (Table 2). Strain
PYR-1 converted all of the PYRdHD to PYRQ at an initial PYRdHD
concentration of 200 µM, whereas at an initial concentration of 50 µM only 4% of the diol was converted to the quinone. This organism
was able to grow on either PYRdHD or PYRQ as a sole carbon source in
MSB medium, as determined by significant increases in optical density
and protein concentration relative to inoculated vessels with no carbon
source (results not shown). The protein yield from PYRQ was the
same as that from 500 µM pyrene under the same conditions, while that
from PYRdHD was about one-third the yield from pyrene or PYRQ.
Effects of pyrene metabolites on phenanthrene degradation.
Apparent first-order rates of phenanthrene degradation were
measured in the presence and absence of PYRdHD and PYRQ at
an initial phenanthrene concentration of 5.6 µM, which is less than its aqueous solubility. PYRdHD strongly inhibited phenanthrene degradation by strains P15 and R1, modestly inhibited phenanthrene degradation by strain P21, and had a negligible effect on strain P16
(Table 3). PYRQ strongly inhibited
phenanthrene degradation by strain R1 and had a negligible-to-minor
effect on the remaining strains.
In contrast to the observed inhibitory effects of pyrene metabolites on
rates of dissolved phenanthrene degradation by some
of the strains, the
yield of protein after growth on 560 µM phenanthrene
for 3 days in
the presence of PYRQ or PYRdHD was equivalent to
the yield obtained
after growth on phenanthrene alone for all
four strains (not shown).
There was no growth on PYRQ or PYRdHD
by any of these
isolates.
Effects of pyrene metabolites on mineralization of BaP.
Both
PYRdHD and PYRQ at concentrations near their aqueous saturation
concentrations strongly inhibited the mineralization of BaP by strains
P15 and R1 throughout a 48-h incubation period (Fig.
3). In addition, PYRQ inhibited BaP
mineralization by both strains at concentrations lower than its aqueous
saturation concentration over a 48-h incubation (Table
4). Radiochromatograms of culture fluids
from incubation of either organism with 1.6 µM PYRQ indicated that no
metabolites accumulated and less BaP was removed than in positive
controls incubated without PYRQ (not shown).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
Mineralization of BaP by P. saccharophila P15
(a) and S. yanoikuyae R1 (b). Each strain was incubated
alone ( ) or in the presence of 155 µM PYRdHD ( ) or 1.6 µM
PYRQ ( ). Data are means and standard deviations of triplicate
measurements at each time point. Unobservable error bars are within the
size of the symbol. Total recoveries of 14C ranged from 79 to 99% for strain P15 and from 95 to 99% for strain R1.
|
|
 |
DISCUSSION |
The ability of PAH-degrading organisms to transform PAH that they
are incapable of mineralizing has been noted previously (1, 20,
31, 47), but the products of such incomplete metabolism have not
been characterized. Partial transformation of pyrene may be
particularly relevant because of an apparently limited diversity in the
ability of PAH-degrading bacteria to mineralize pyrene. The ability to
grow on or mineralize pyrene is primarily associated with actinomycetes
(25, 26), whereas a diverse group of bacteria isolated from
PAH-contaminated soils by enrichment with phenanthrene can remove
pyrene without mineralizing it (1).
Pyrene transformation by P. stutzeri P16 and B. cereus P21 during active growth on phenanthrene leads to the
formation of significant amounts of PYRdHD as an apparently terminal,
or "dead-end," metabolite. PYRdHD has been identified as an
intermediate in the degradation of pyrene by a number of strains that
can grow on or mineralize pyrene (13, 24, 33, 35, 49). It
also has been found in pyrene-contaminated marine sediments
(30) and has accumulated when pyrene was added to enrichment
cultures derived from the sediment (29). The formation of a
cis-dihydrodiol from pyrene is consistent with its oxidation
via a PAH dioxygenase, an enzyme class for which examples from several
bacteria are known to have broad substrate ranges (14, 15, 18, 27,
28, 34, 37, 46).
When grown on phenanthrene in the presence of pyrene,
S. yanoikuyae R1 accumulated significant amounts
of PYRdHD and PYRQ in the medium, although only PYRQ was detected
when [14C]pyrene was incubated with resting cells (Fig.
2d). Formation of PYRQ probably proceeds by subsequent metabolism of
PYRdHD, as both strains R1 and P15 converted PYRdHD essentially
stoichiometrically to PYRQ (Table 1). PYRQ has not been observed
previously as an intermediate in the degradation of pyrene, but
o-quinones such as PYRQ can arise from the autoxidation of
an o-dihydroxy intermediate (7, 12, 32). We were
not able to isolate 4,5-dihydroxypyrene, nor has it been isolated in
previous work with pyrene-degrading organisms. Since
4,5-dihydroxypyrene is rapidly oxidized to PYRQ in air at ambient
conditions (41), PYRQ presumably results from the
autoxidation of 4,5-dihydroxypyrene.
P. saccharophila P15 can convert PYRdHD to PYRQ, but neither
metabolite was identified in either growing- or resting-cell incubations of this organism with pyrene. The radiochromatograms from
resting cell incubations of strains P15 and R1 (Fig. 2) indicate that
other nonmineral products were formed by these organisms. We do not
believe that these other products are metabolites further down
the known pyrene degradation pathway, such as phenanthrene-dicarboxylic acid or phenanthrene-carboxylic acid. When the HPLC conditions used to
analyze culture fluids were optimized for the fluorescence detection of
the phenanthrene aromatic skeleton, no such peaks were detected in
culture fluids from any of the strains. In addition, degradation
beyond phenanthrene-dicarboxylic acid should result in the formation of
14CO2, since the [14C]pyrene used
in these experiments is labeled at the 4,5 position.
When isotope trapping with PYRdHD was used to examine the
transformation of pyrene by strain P15, a single product accumulated that elutes at the same retention time as PYRQ (Fig. 2a). This result,
and the relatively facile oxidation of PYRdHD to PYRQ by this organism,
suggests that pyrene metabolism by strain P15 probably does
proceed via oxidation at the 4,5 bond. When incubated with a large
excess of PYRdHD, intracellular concentrations of 4,5-dihydroxypyrene are likely to be far greater than during the metabolism of pyrene alone. Under these conditions, the autoxidation of
4,5-dihydroxypyrene could be favored over other reactions in which this
intermediate may be involved.
The unidentified products from pyrene transformation by strain P15 (and
possibly strain R1) most likely represent adducts from the reaction of
one or more pyrene metabolites with cellular constituents. The
formation of such adducts is consistent with the presence of an
insoluble residue when both strains were incubated with radiolabeled
pyrene. Based on the accumulation of PYRQ in the isotope-trapping
experiment, the reactive metabolite may be pyrene-4,5-dihydriodiol or a
reactive intermediate derived from its intracellular oxidation. We rule
out covalent reaction of PYRQ with cellular or buffer constituents,
even though o-quinones derived from naphthalene and BaP can
form conjugates in phosphate and glycine buffers and can also form
adducts with nucleophiles such as cysteine and glutathione
(32). We recovered 100% of the added PYRQ incubated with
strains P15 or R1 for 3 days (not shown), and PYRQ also accumulated
stoichiometrically with the removal of PYRdHD by these organisms.
Mycobacterium PYR-1 surprisingly formed significant
amounts of PYRQ when incubated with a high concentration of
PYRdHD, although it was not formed when strain PYR-1 was grown on
pyrene. Similar to the isotope-trapping experiment with strain P15, it
is likely that the rate of formation of 4,5-dihydroxypyrene at high
concentrations of PYRdHD exceeds the subsequent rate of metabolism,
resulting in the accumulation of 4,5-dihydroxypyrene and its
consequent autoxidation to PYRQ. A similar phenomenon has been
noted before in the bacterial degradation of naphthalene, for which the
accumulation of naphthoquinone has been suggested to increase as
the rate of naphthalene availability increased (2, 19).
Strain PYR-1 is able to consume PYRQ as a growth substrate, which
suggests that it would only accumulate transiently if formed by this
organism or by other bacteria that might also be transforming pyrene in a complex system. It would be of interest to know if other
organisms capable of growing on or mineralizing pyrene are able to
degrade PYRQ, as our work suggests that PYRQ has the potential to
accumulate in PAH-contaminated systems that contain organisms
incapable of more extensive pyrene metabolism.
Effects of pyrene metabolites on the degradation of other
PAH.
The present study clearly demonstrated that
extracellular metabolites from the partial transformation of one PAH
substrate can adversely affect the metabolism of other PAH. Both
PYRdHD and PYRQ led to decreased rates of phenanthrene degradation by at least one of the organisms tested (Table 3). These effects did
not appear to result from irreversible reactions of the metabolites or
reactive species derived from them, since neither metabolite inhibited the growth of any strain when phenanthrene was present as a sole carbon source in excess of its aqueous solubility.
The ability of PYRdHD and PYRQ to virtually block BaP mineralization by
both strains P15 and R1 (Fig.
3) is important, as
BaP appears to be
particularly recalcitrant in contaminated soil
systems (
5,
11,
21). Cornelissen et al. (
11) have suggested
that the
recalcitrance of BaP and other high-molecular-weight
PAH in
contaminated soils is due to unexplained biological factors
rather than
to limitations in the bioavailability of these compounds.
Combined with
the possibility that BaP degradation can be much
slower than that of
other PAH (
8), the accumulation of inhibitory
metabolites could lead to long-term persistence in PAH-contaminated
systems.
The mechanisms of inhibition by pyrene metabolites observed in
this study are not apparent. It is possible that PYRdHD could
competitively inhibit a dihydrodiol dehydrogenase utilized in
the
degradation of BaP or phenanthrene by strains P15 and R1,
as it clearly
is a substrate for these organisms. Alternatively,
PYRdHD could inhibit
BaP mineralization via the formation of PYRQ,
which also inhibited BaP
mineralization by strains P15 and R1.
As discussed above, PYRQ does not
appear to react covalently with
cellular constituents, although it is
possible that only a small
concentration of PYRQ is required to react
with a critical enzyme
or other constituent. However, in this case we
would expect inhibition
to be independent of PYRQ concentration, since
PYRQ would be present
in large excess at all concentrations. This
was clearly not the
case in the mineralization of BaP (Table
4). We
also rule out
competitive effects of PYRQ as an explanation for the
inhibition
of BaP oxidation; we would have expected such competition to
lead
to the accumulation of BaP metabolites, but this was not observed
with radiochromatography. A possible explanation for the inhibitory
effects of PYRQ is its potential to mediate futile redox reactions
that
could alter the balance of vital redox cofactors, as has
been observed
for other PAH
o-quinones (
32).
Other considerations.
The potential fates of extracellular
metabolites such as PYRdHD and PYRQ in a contaminated soil or sediment
system are important to consider. Microbial consortia can lead to more
extensive degradation of PAH than can be achieved with pure cultures
(6, 42), and in some cases such consortia can degrade
metabolites that otherwise would accumulate (6, 29). If
pyrene-mineralizing organisms are not present in systems in which
pyrene metabolites accumulate to inhibitory levels, it may be possible
to enhance overall PAH degradation by inoculating the system with
organisms capable of degrading the metabolites.
Abiotic reactions of pyrene metabolites with soil constituents,
particularly natural organic matter (NOM), may also be important.
Radiolabel originating from [
14C]pyrene has been shown to
interact with NOM at long incubation
times in soil (
22), and
quinones are known to undergo oxidation-reduction
reactions with NOM
(
36). Furthermore, the aqueous solubility
of PYRQ (0.37 mg/l) is 2 orders of magnitude lower than that of
PYRdHD; thus, PYRQ
has the potential to precipitate in some systems,
which might influence
its subsequent degradation. The potential
accumulation of
o-quinones derived from PAH in contaminated systems
also
needs to be evaluated from a human risk assessment standpoint,
since a
variety of such
o-quinones have been shown to be cytotoxic
and mutagenic and to form DNA adducts in mammalian cells
(
32).
Transient increases in mutagenicity and toxicity have
been observed
in PAH-contaminated soils undergoing active
bioremediation (
3,
16), which might be explained by the
presence of PAH metabolites
such as those described
here.
 |
ACKNOWLEDGMENTS |
We thank Ramiah Sangaiah for synthesizing PYRdHD and for
performing 1H NMR analyses.
This research was funded by the National Institute of Environmental
Health Sciences (grant P42ES05948) under the Superfund Basic Research Program.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Environmental Sciences and Engineering, CB #7400, University of North Carolina, Chapel Hill, NC 27599-7400. Phone: (919) 966-3860. Fax: (919)
966-7911. E-mail: mike_aitken{at}unc.edu.
 |
REFERENCES |
| 1.
|
Aitken, M. D.,
W. T. Stringfellow,
R. D. Nagel,
C. Kazunga, and S.-H. Chen.
1998.
Characteristics of phenanthrene-degrading bacteria isolated from soils contaminated with polycyclic aromatic hydrocarbons.
Can. J. Microbiol.
44:743-752[CrossRef][Medline].
|
| 2.
|
Auger, R. L.,
A. M. Jacobson, and M. M. Domach.
1995.
Effect of nonionic surfactant addition on bacterial metabolism of naphthalene: assessment of toxicity and overflow metabolism potential.
J. Hazard. Mater.
43:263-272[CrossRef].
|
| 3.
|
Belkin, S.,
M. Steiber,
A. Tiehm,
F. Frimmel,
A. Abeliovich,
P. Werner, and S. Ulitzur.
1994.
Toxicity and genotoxicity enhancement during polycyclic aromatic hydrocarbons' degradation.
Environ. Toxicol. Water Qual.
9:303-309.
|
| 4.
|
Boyd, D. R.,
N. D. Sharma,
R. Agarwal,
S. M. Resnick,
M. J. Schocken,
D. T. Gibson,
J. M. Sayer,
H. Yagi, and D. M. Jerina.
1997.
Bacterial dioxygenase-catalysed dihydroxylation and chemical resolution routes to enantiopure cis-dihydrodiols of chrysene.
J. Chem. Soc. Perkins Trans. I
1:1715-1723.
|
| 5.
|
Carmichael, L. M., and F. K. Pfaender.
1997.
Polynuclear aromatic hydrocarbon metabolism in soils: relationship to soil characteristics and preexposure.
Environ. Toxicol. Chem.
16:666-675[CrossRef].
|
| 6.
|
Casellas, M.,
M. Grifoll,
J. Sabaté, and A. M. Solanas.
1998.
Isolation and characterization of a 9-fluorenone-degrading bacterial strain and its role in synergistic degradation of fluorene by a consortium.
Can. J. Microbiol.
44:734-742[CrossRef].
|
| 7.
|
Cavalotti, C.,
F. Orsini, and G. Sello.
1999.
1,2-Dihydro-1,2-dihydroxynaphthalene dehydrogenase containing recombinant strains: preparation, isolation and characterization of 1,2-dihydroxynaphthalenes and 1,2-naphthoquinones.
Tetrahedron
55:4467-4480[CrossRef].
|
| 8.
|
Chen, S.-H., and M. D. Aitken.
1999.
Salicylate stimulates the degradation of high-molecular weight polycyclic aromatic hydrocarbons by Pseudomonas saccharophila P15.
Environ. Sci. Technol.
33:435-439[CrossRef].
|
| 9.
|
Cho, H., and R. G. Harvey.
1974.
Synthesis of "K-region" quinones and arene oxides of polycyclic aromatic hydrocarbons.
Tetrahedron Lett.
16:1491-1494[CrossRef].
|
| 10.
|
Cook, J. W., and R. Schoental.
1948.
Oxidation of carcinogenic hydrocarbons by osmium tetroxide.
J. Chem. Soc.
1948:170-173[CrossRef].
|
| 11.
|
Cornelissen, G.,
H. Rigterink,
M. M. A. Ferdinandy, and P. C. M. Van Noort.
1998.
Rapidly desorbing fractions of PAHs in contaminated sediments as a predictor of the extent of bioremediation.
Environ. Sci. Technol.
32:966-970[CrossRef].
|
| 12.
|
Davies, J. I., and W. C. Evans.
1964.
Oxidative metabolism of naphthalene by soil pseudomonads.
J. Biochem.
91:251.
|
| 13.
|
Dean-Ross, D., and C. E. Cerniglia.
1996.
Degradation of pyrene by Mycobacterium flavescens.
Appl. Microbiol. Biotechnol.
46:307-312[CrossRef][Medline].
|
| 14.
|
Denome, S. A.,
D. C. Stanley,
E. S. Olson, and K. D. Young.
1993.
Metabolism of dibenzothiophene and naphthalene in Pseudomonas strains: complete DNA sequence of an upper naphthalene catabolic pathway.
J. Bacteriol.
175:6890-6901[Abstract/Free Full Text].
|
| 15.
|
Di Gennaro, P.,
G. Sello,
D. Bianchi, and P. D'Amico.
1997.
Specificity of substrate recognition by Pseudomonas fluorescens N3 dioxygenase.
J. Biol. Chem.
272:30254-30260[Abstract/Free Full Text].
|
| 16.
|
Donnelly, K. C.,
C. S. Anderson,
J. C. Thomas,
K. W. Brown,
D. J. Manek, and S. H. Safe.
1992.
Bacterial mutagenicity of soil extracts from a bioremediation facility treating wood-preserving waste.
J. Hazard. Mater.
30:71-81[CrossRef].
|
| 17.
|
Fatiadi, A. J.
1974.
New applications of periodic acid and periodates in organic and bio-organic chemistry.
Synthesis
4:229-257.
|
| 18.
|
Foght, J. M., and D. W. S. Westlake.
1996.
Transposon and spontaneous deletion mutants of plasmid-borne genes encoding polycyclic aromatic hydrocarbon degradation by a strain of Pseudomonas fluorescens.
Biodegradation
7:353-366[CrossRef][Medline].
|
| 19.
|
Ghoshal, S., and R. G. Luthy.
1998.
Biodegradation kinetics of naphthalene in nonaqueous phase liquid-water mixed batch systems: comparison of model predictions and experimental results.
Biotechnol. Bioeng.
57:356-366[CrossRef][Medline].
|
| 20.
|
Grifoll, M.,
S. A. Selifonov,
C. V. Gatlin, and P. J. Chapman.
1995.
Actions of a versatile fluorene-degrading bacterial isolate on polycyclic aromatic compounds.
Appl. Environ. Microbiol.
61:3711-3723[Abstract].
|
| 21.
|
Grosser, R. J.,
D. Warshawsky, and J. R. Vestal.
1995.
Mineralization of polycyclic and N-heterocyclic aromatic compounds in hydrocarbon-contaminated soils.
Environ. Toxicol. Chem.
14:375-382.
|
| 22.
|
Guthrie, E. A., and F. K. Pfaender.
1998.
Reduced pyrene bioavailability in microbially active soils.
Environ. Sci. Technol.
32:501-508[CrossRef].
|
| 23.
|
Harvey, R. G.,
S. W. Goh, and C. Cortez.
1975.
"K-region" oxides and related oxidized metabolites of carcinogenic aromatic hydrocarbons.
J. Am. Chem. Soc.
97:3468-3479[CrossRef][Medline].
|
| 24.
|
Heitkamp, M. A.,
J. P. Freeman,
D. W. Miller, and C. E. Cerniglia.
1988.
Pyrene degradation by a Mycobacterium sp.: identification of ring oxidation and ring fission products.
Appl. Environ. Microbiol.
54:2556-2565[Abstract/Free Full Text].
|
| 25.
|
Kästner, M.,
M. Breuer-Jammali, and B. Mahro.
1994.
Enumeration and characterization of the soil microflora from hydrocarbon-contaminated soil sites able to mineralize polycyclic aromatic hydrocarbons (PAH).
Appl. Microbiol. Biotechnol.
41:267-273[CrossRef].
|
| 26.
|
Kelley, I., and C. E. Cerniglia.
1995.
Degradation of a mixture of high-molecular-weight polycyclic aromatic hydrocarbons by a Mycobacterium strain PYR-1.
J. Soil Contam.
4:77-91.
|
| 27.
|
Kiyohara, H.,
S. Torigoe,
N. Kaida,
T. Asaki,
T. Iida,
H. Hayashi, and N. Takizawa.
1994.
Cloning and characterization of a chromosomal gene cluster, pah, that encodes the upper pathway for phenanthrene and naphthalene utilization by Pseudomonas putida OUS82.
J. Bacteriol.
176:2439-2443[Abstract/Free Full Text].
|
| 28.
|
Laurie, A. D., and G. Lloyd-Jones.
1999.
The phn genes of Burkholderia sp. strain RP007 constitute a divergent gene cluster for polycyclic aromatic hydrocarbon catabolism.
J. Bacteriol.
181:531-540[Abstract/Free Full Text].
|
| 29.
|
Li, X.-F.,
W. R. Cullen,
K. J. Reimer, and X.-C. Le.
1996.
Microbial degradation of pyrene and characterization of a metabolite.
Sci. Total Environ.
177:17-29[CrossRef].
|
| 30.
|
Li, X.-F.,
X.-C. Le,
C. D. Simpson,
W. R. Cullen, and K. J. Reimer.
1996.
Bacterial transformation of pyrene in a marine environment.
Environ. Sci. Technol.
30:1115-1119[CrossRef].
|
| 31.
|
Mahaffey, W. R.,
D. T. Gibson, and C. E. Cerniglia.
1988.
Bacterial oxidation of chemical carcinogens: formation of polycyclic aromatic acids from benz[a]anthracene.
Appl. Environ. Microbiol.
54:2415-2423[Abstract/Free Full Text].
|
| 32.
|
Penning, T. M.,
M. E. Burczynski,
C.-F. Hung,
K. D. McCoull,
N. T. Palackal, and L. S. Tsuruda.
1999.
Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones.
Chem. Res. Toxicol.
12:1-18[CrossRef][Medline].
|
| 33.
|
Rehmann, K.,
H. P. Noll,
C. E. W. Steinberg, and A. A. Kettrup.
1998.
Pyrene degradation by Mycobacterium sp. strain KR2.
Chemosphere
36:2977-2992[Medline].
|
| 34.
|
Resnick, S. M.,
K. Lee, and D. T. Gibson.
1996.
Diverse reactions catalyzed by naphthalene dioxygenase from Pseudomonas sp. strain NCIB 9816.
J. Ind. Microbiol.
17:438-457.
|
| 35.
|
Schneider, J.,
R. Grosser,
K. Jayasimhulu,
W. Xue, and D. Warshawsky.
1996.
Degradation of pyrene, benz[a]anthracene, and benzo[a]pyrene by Mycobacterium sp. strain RJGII-135, isolated from a former coal gasification site.
Appl. Environ. Microbiol.
62:13-19[Abstract].
|
| 36.
|
Scott, D. T.,
D. M. McKnight,
E. L. Blunt-Harris,
S. E. Kolesar, and D. R. Lovley.
1998.
Quinone moieties act as electron acceptors in the reduction of humic substances by humics-reducing microorganisms.
Environ. Sci. Technol.
32:2984-2989[CrossRef].
|
| 37.
|
Selifonov, S. A.,
M. Grifoll,
R. W. Eaton, and P. J. Chapman.
1996.
Oxidation of naphthenoaromatic and methyl-substituted aromatic compounds by naphthalene 1,2-dioxygenase.
Appl. Environ. Microbiol.
62:507-514[Abstract].
|
| 38.
|
Stringfellow, W. T., and M. D. Aitken.
1994.
Comparative physiology of phenanthrene degradation by two dissimilar pseudomonads isolated from a creosote-contaminated soil.
Can. J. Microbiol.
40:432-438[Medline].
|
| 39.
|
Stucki, G.,
R. Gälli,
H.-R. Ebersold, and T. Leisinger.
1981.
Dehalogenation of dichloromethane by cell extracts of Hyphomicrobium DM2.
Arch. Microbiol.
130:366-371[CrossRef].
|
| 40.
|
Sutherland, J. B.,
F. Rafii,
A. A. Khan, and C. E. Cerniglia.
1995.
Mechanisms of polycyclic aromatic hydrocarbon degradation, p. 269-306.
In
L. Y. Young, and C. E. Cerniglia (ed.), Microbial transformation and degradation of toxic organic chemicals. Wiley-Liss, New York, N.Y.
|
| 41.
|
Tintel, C.,
J. Terheijden,
J. Lugtenburg, and J. Cornelisse.
1987.
Photoreduction and photoaddition reactions of pyrenediones.
Tetrahedron Lett.
28:2057-2060[CrossRef].
|
| 42.
|
Trzesicka-Mlynarz, D., and O. P. Ward.
1995.
Degradation of polycyclic aromatic hydrocarbons (PAHs) by a mixed culture and its component pure cultures, obtained from PAH-contaminated soil.
Can. J. Microbiol.
41:470-476[Medline].
|
| 43.
|
U.S. Environmental Protection Agency.
1996.
Innovative treatment technologies: annual status report, 8th ed.
EPA-542-R-96-010. U.S. Environmental Protection Agency, Washington, D.C.
|
| 44.
|
U.S. Environmental Protection Agency.
1999.
Use of monitored natural attenuation at superfund, RCRA corrective action and underground storage tank sites. OSWER Directive no. 9200.4-17P. U.S.
Environmental Protection Agency, Washington, D.C.
|
| 45.
|
Wilson, S. C., and K. C. Jones.
1993.
Bioremediation of soil contaminated with polynuclear aromatic hydrocarbons (PAHs): a review.
Environ. Pollut.
81:229-249.
|
| 46.
|
Yang, Y.,
R. F. Chen, and M. P. Shiaris.
1994.
Metabolism of naphthalene, fluorene, and phenanthrene: preliminary characterization of a cloned gene cluster from Pseudomonas putida NCIB 9816.
J. Bacteriol.
176:2158-2164[Abstract/Free Full Text].
|
| 47.
|
Ye, D.,
M. A. Siddiqi,
A. E. Maccubbin,
S. Kumar, and H. C. Sikka.
1996.
Degradation of polynuclear aromatic hydrocarbons by Sphingomonas paucimobilis.
Environ. Sci. Technol.
30:136-142[CrossRef].
|
| 48.
|
Young, E. R. R., and R. L. Funk.
1998.
A practical synthesis of pyrene-4,5-dione.
J. Org. Chem.
63:9995-9996[CrossRef].
|
| 49.
|
Zylstra, G. J.,
X. P. Wang,
E. Kim, and V. A. Didolkar.
1994.
Cloning and analysis of the genes for polycyclic aromatic hydrocarbon degradation.
Ann. N. Y. Acad. Sci.
721:386-398[Medline].
|
Applied and Environmental Microbiology, May 2000, p. 1917-1922, Vol. 66, No. 5
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Liang, Y., Gardner, D. R., Miller, C. D., Chen, D., Anderson, A. J., Weimer, B. C., Sims, R. C.
(2006). Study of Biochemical Pathways and Enzymes Involved in Pyrene Degradation by Mycobacterium sp. Strain KMS. Appl. Environ. Microbiol.
72: 7821-7828
[Abstract]
[Full Text]
-
Jouanneau, Y., Meyer, C.
(2006). Purification and Characterization of an Arene cis-Dihydrodiol Dehydrogenase Endowed with Broad Substrate Specificity toward Polycyclic Aromatic Hydrocarbon Dihydrodiols.. Appl. Environ. Microbiol.
72: 4726-4734
[Abstract]
[Full Text]
-
Lalucat, J., Bennasar, A., Bosch, R., Garcia-Valdes, E., Palleroni, N. J.
(2006). Biology of Pseudomonas stutzeri. Microbiol. Mol. Biol. Rev.
70: 510-547
[Abstract]
[Full Text]
-
Vinas, M., Sabate, J., Espuny, M. J., Solanas, A. M.
(2005). Bacterial Community Dynamics and Polycyclic Aromatic Hydrocarbon Degradation during Bioremediation of Heavily Creosote-Contaminated Soil. Appl. Environ. Microbiol.
71: 7008-7018
[Abstract]
[Full Text]
-
Zielinska-Park, J., Nakamura, J., Swenberg, J. A., Aitken, M. D.
(2004). Aldehydic DNA lesions in calf thymus DNA and HeLa S3 cells produced by bacterial quinone metabolites of fluoranthene and pyrene. Carcinogenesis
25: 1727-1733
[Abstract]
[Full Text]
-
Van Hamme, J. D., Singh, A., Ward, O. P.
(2003). Recent Advances in Petroleum Microbiology. Microbiol. Mol. Biol. Rev.
67: 503-549
[Abstract]
[Full Text]